Regen Biopharma Inc (RGBP) Annual Balance Sheets

Annual · GAAP · USD millions
Access RGBP quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Regen Biopharma Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Sep 30 2025)
(Sep 30 2024) (Sep 30 2023) (Sep 30 2022) (Sep 30 2021)
Assets
Cash & cash equivalent0.07
Marketable Securities, Current SH0.00
Cash & Short-term Investments0.00
Accounts receivable0.20
Other Receivables0.00
Other Current Assets0.00
Prepaid Expense, Current AS0.00
Total Current Assets0.27
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Investment Securities Related Party-
Total Assets0.27
Liabilities
Accounts Payable, Current AC0.00
Accrued Liabilities, Current AC1.84
Derivative Liability LI2.08
Notes Payable, Current NO0.19
Other Liabilities, Current0.10
Deferred Revenue, Current DE1.34
Total Current Liabilities6.56
Long-term debt0.00
Convertible Notes Payable NO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Convertible Note Payable Current1.01
Accounts Payables And Accrued Liabilities Current-
Convertible Notes Payable Related Parties Less Unamortized Discount-
Total Liabilities6.56
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock15.63
Retained Earnings / Accumulated Deficit-21.69
Other Equity-0.22
Common Stockholder's Equity-6.28
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-6.28
Liabilities & Stockholder's Equity0.27
4 historic quarters locked

Sign in to unlock the full Regen Biopharma Inc balance sheet history.

About Regen Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20250930)
  • Filed with the SEC: December 30, 2025
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-25-029526

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License